Sentences with phrase «new tumors from»

In the laboratory animal study, ursolic acid, the active compound in holy basil, combined with radiation was more effective at inducing skin cancer cell death and inhibiting new tumors from forming than radiation alone.

Not exact matches

A new study, conducted by the U.S. National Toxicology Program, found that rats consistently exposed to radiofrequency radiation from cellphones were more likely to develop malignant tumors in the brain and heart.
Immunotherapy differs from more traditional cancer treatments, such as surgery (cutting malignant cells out of the body), chemotherapy and radiation (poisoning the deadly mutants), and even the newer, more precise molecular drugs that attempt to jam the protein signals that tell tumor cells to keep dividing and conquering.
It has already invested in some companies that graduated from the Labs incubator, including Modern Meadow, a New Jersey — based startup that's biofabricating leather without the need for animals, and 3Scan, a company that enables 3D analysis of tumors and organs.
Chicago, GenomeWeb — A new study by researchers from Memorial Sloan Kettering Cancer Center has demonstrated the predictive power of an AR - V7 protein expression test using Epic Sciences» non-EPCAM-based circulating tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate cancer.
At a time when individual tribulations seem to have grown with increasingly difficult economic times, it's no wonder that the ballroom was filled with at least 200 people from as far as New York, New Jersey and Virginia, many with testimonies of being cured of ailments from chronic sinus issues and financial woes, to smoking cessation and the disappearance of tumors.
In 2010, researchers from the University of Michigan Comprehensive Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cells.
It was confirmed June 29 and I love the keto diet because not only is it helping me heal chemo side - effects from 2000/2001, I can feel a new freedom in my abdomen, I know it's clearing tumors away.
After John's diagnosis, when Isabella was in third grade, the family relocated from North Carolina to Michigan, then later, on to New York and Minnesota as John underwent surgeries to remove tumors, implant pain pumps and reconstruct parts of his skull.
NEW YORK (CBSNewYork / AP)-- The New York assemblyman accused of asking young female staffers to massage him, touch his cancerous tumors and join him in hotel rooms said Saturday he will resign rather than possibly be expelled from the Legislature amid sexual harassment allegatioNEW YORK (CBSNewYork / AP)-- The New York assemblyman accused of asking young female staffers to massage him, touch his cancerous tumors and join him in hotel rooms said Saturday he will resign rather than possibly be expelled from the Legislature amid sexual harassment allegatioNew York assemblyman accused of asking young female staffers to massage him, touch his cancerous tumors and join him in hotel rooms said Saturday he will resign rather than possibly be expelled from the Legislature amid sexual harassment allegations.
These discoveries were made by oncologist Dr. Michael Kühn from the Department of Internal Medicine III, which is a part of the University Center for Tumor Diseases (UCT) at the Mainz University Medical Center, in a collaborative effort with researchers from the Memorial Sloan - Kettering Cancer Center in New York and Harvard University in Boston.
Unlike conventional chemotherapies and radiation that indiscriminately eradicate fast - growing tissues and ravage people's bodies with side effects, new therapies specifically target tumors using tailored cells from individual patients.
A new study by Dana - Farber Cancer Institute scientists suggests it may be possible to prevent tumors from recurring and to eradicate metastatic growths by implanting a gel containing immunotherapy during surgical removal of a tumor.
Isaacson's surgical team is helping pioneer a new minimally invasive procedure that extracts vertigo - inducing tumors from the inner ear without having to remove a large piece of skull.
Moreover, the combo prevented any new breast tumors from appearing.
Researchers at the University of Cincinnati (UC) College of Medicine have shown that a new targeted treatment could benefit patients with certain pancreatic tumors by preventing spread of the cancer and protecting their heart from damage — a direct result of the tumor.
«This gives us novel and exciting new therapeutic options to pursue based on results from drug screenings of primary tumor samples from patients.»
Comparing the metastasized tumors with the original breast tumors, the researchers were surprised to learn that multiple, slightly genetically different cells from the original site had broken away together and established the new tumors.
The initial experiments made use of cancer cells that Quiñones - Hinojosa and his team removed from willing patients and grew in the laboratory until they formed little spheres of cells, termed oncospheres, likely to be the most resistant to chemotherapy and radiation, and capable of creating new tumors.
In a new study, a team found that injecting mice with tiny magnets and cranking up the heat eliminated tumors from the animals» bodies with no apparent side effects.
Now a team of researchers in China has developed a new microfluidic chip that can quickly and efficiently segregate and capture live circulating tumor cells (CTCs) from a patient's blood, with potential applications for cancer screenings and treatment assessments.
A team under Professor Scheffler, consisting of researchers from the Bonn University Hospital, the Life & Brain Center, The German Consortium for Translational Cancer Research, Tufts University Boston / Massachusetts, and other institutes in the USA, has now developed a new method that is expected to combat such complex brain tumors better.
A randomized phase III trial finding that a new monoclonal antibody, elotuzumab, added to standard therapy, extended the duration of remission for patients with relapsed multiple myeloma by about five months Findings from two phase III studies showing that children with Wilms tumor who have a specific chromosomal abnormality do better with a more intensive, augmented chemotherapy regimen
Biopsied tumor tissue from all 60 new patients was fixed in formalin and embedded in paraffin so that TMEM sites in the tissue could be counted.
It is well established that melanoma cells can spread through the blood to accumulate and form new tumors (metastases) in other parts of the body away from the original tumor.
A new investigation of more than 48,000 stored tumor samples finds evidence of a key deficiency in a repair mechanism designed to keep DNA from being mutated and causing cancer.
The new «tumor in a dish» method begins by taking the cancerous tissue removed during surgery or biopsy, cutting it up into small pieces and putting them in a special collagen gel that maintains them as «organoids» that retain the three - dimensional structure of the original tumor and include supporting cells from the tumor's environment.
Bone metastases happen when cancer cells travel from the primary tumor site to the bone, establishing a new cancer location.
The new study overcame this limitation by selectively dissecting cancer cells from pieces of tumor tissue.
Lee's study results, which appear in the July 16, 2015 issue of Nature Communications, revealed new understanding about how 14 -3-3 sigma — a cell cycle «controller» - regulates cancer metabolic programming, thus protecting healthy cells from turning into tumor - producing factories.
In the past few years, Vogelstein and Kinzler have shifted away from discovering new cancer genes to a less glamorous pursuit: using genetic tests to detect common tumors as early as possible, when they are easiest to cure.
Researchers from Northwestern Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago have revealed new insight into how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma (DIPG), may develop.
Orchestrating a successful immune attack against tumors has proven difficult so far, but a new study from MIT suggests that such therapies could be improved by simultaneously activating both arms of the immune system.
New research from George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, finds liquid biopsies from blood tests and DNA sequencing can detect a return of ovarian cancer long before a tumor reappears.
This is critical if we are to develop new treatments to prevent epilepsy from developing after a head injury, stroke, or brain tumor
Metastasis is the process in which cells from a primary tumor break - off, enter the blood stream and create new tumors elsewhere in the body.
Study leader Fausto J. Rodriguez, M.D., associate professor of pathology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center, says the new study sought to sort out what makes the more aggressive NF1 - related tumors genetically different from low grade tumors and normal, healthy cells.
This allows cancer cells to break off from tumors, spread throughout the body (in blood or other fluid) and form new tumors at distant sites — a process called metastasis.
Siva Vanapalli, an associate professor in the Department of Chemical Engineering, at Texas Tech University, recently received two grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to study the movement of tumor cells throughout the body and new methods of detecting cancer cells.
A new guideline from the U.S. Multi-Society Task Force on Colorectal Cancer recommends genetic testing of tumors for all newly diagnosed colorectal cancer patients.
In a development that could lead to a new generation of drugs to precisely treat a range of diseases, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time designed a drug candidate that decreases the growth of tumor cells in animal models in one of the hardest to treat cancers — triple negative breast cancer.
Insights into how cells move through the body could lead to innovative techniques to stop cancer cells from spreading and causing secondary tumors, according to new UCL research.
Research from Rutgers Cancer Institute of New Jersey examining difficult to treat cancer tumors through genomic profiling shows that tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the tumor originated in the body.
In a new study, Yale Cancer Center researchers identified a novel genetic defect that prevents brain tumor cells from repairing damaged DNA.
The results from our new study suggest that entinostat may enhance the anti-tumor efficacy of PD - 1 targeted therapy through MDSC targeting, potentially providing an effective combination treatment approach for patients with solid tumors, including lung and renal cell carcinoma.»
Research from Rutgers Cancer Institute of New Jersey shows that the «first in human» series of vaccine injections given directly into a pancreatic cancer tumor is not only well tolerated, but also suggests an «encouraging» period of stable disease.
In several steps using a new strategy and a novel drug, Burkhard Becher's team from the Institute of Experimental Immunology at the University of Zurich has now succeeded in doing exactly this in the case of glioblastoma, one of the most dangerous brain tumors.
One goal of drug designers has been to prevent tumors from making new blood vessels, a process known as angiogenesis.
Improving the understanding of these genetic changes in these diseases, can point to new directions for diagnosis and treatment, including a way to potentially differentiate aggressive tumors from those that are not life threatening.
In order to enhance the diagnosis of CNS tumors, a team led by Professor Stefan Pfister, KiTZ director and department head of «Pediatric Neurooncology» at the DKFZ, in collaboration with colleagues from the Neuropathology Department at Heidelberg University Hospital led by Professor Andreas von Deimling, have developed a new computer - based method.
a b c d e f g h i j k l m n o p q r s t u v w x y z